U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving Novo Nordisk's highly anticipated oral GLP-1 drug – with a starting dose ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

The approval of the Wegovy pill comes months before Novo Nordisk rival Eli Lilly and Company expects FDA approval of its ...

This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill ...

Everyone hoping for a slimmed down 2026 got a boost with the news the US Food and Drug Administration has approved a pill version of the weight-loss drug Wegovy, making it the first in this new era.

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The Wegovy pill is FDA-approved to reduce excess body weight and maintain weight reduction long-term in adults who have ...

A pill version of the popular GLP-1 weight-loss drug Wegovy has been green-lit for use in the U.S. Here’s what that means for ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

The FDA has approved Novo Nordisk's pill version of Wegovy, making it the first oral GLP-1 receptor agonist therapy cleared for chronic weight ...

The U.S. Food and Drug Administration's approval of an oral version of Novo Nordisk's weight-loss drug Wegovy could ...